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Increasing evidence has suggested that natural killer (NK) cells contribute to
the pathogenesis of human immunological liver injury (ILI). Previous studies have
demonstrated that Sophocarpine exerts activity in immune modulation. It also has a
therapeutic effect on liver protection in that it can alleviate liver fibrosis by suppressing
both the activation of hepatic stellate cells and the proliferation of the activated hepatic
stellate cells. However, whether Sophocarpine protects the liver by regulating NK cell
activity remains unclear. In this study, the modulating effect of Sophocarpine on NK
cells in the liver was investigated. The results showed that Sophocarpine dramatically
decreased the production of pro-inflammatory cytokines and attenuated the liver injury
induced by Poly I: C/D-GalN in C57BL/6- mice. More importantly, Sophocarpine pre-
treatment significantly suppressed NK cell activation and downregulated the expression
of NKG2D, a receptor responsible for NK cell activation. Moreover, the protein levels of
DAP12, ZAP76 and Syk decreased, as did their corresponding mRNA levels. Overall,
our study demonstrates that Sophocarpine inhibits NK cell activity, thus making it a
promising therapy for ILI.
Keywords: NK cell activity, Sophocarpine, NKG2D-DAP12, immunological liver injury, Poly I: C/D-GalN
INTRODUCTION
Immunological liver injury is a common type of liver damage that is characterized by the severe
infiltration of a large number of inflammatory cells into the liver tissue, which leads to an
inflammatory response and then to immune response-based liver damage (Hajime and Gregory,
2003; Nakamoto and Kaneko, 2003; Tsutsui et al., 2003; Yin and Ding, 2003). As a predominant
organ responsible for innate immunity, the liver plays a critical role in the maintenance of
homeostasis, and ILI has attracted increasing concern. NK cells, which are an essential part of
the innate immune system, exert a quick response when the human body is invaded by exogenous
pathogens or by virus-infected and transformed cells (Trinchieri, 1989; Scott and Trinchieri, 1995;
Biron et al., 1999). However, it has been shown that NK cells can kill hepatocytes and cause
Abbreviations: ILI, immunological liver injury; NK, natural killer; Poly I: C and D-GalN group (PD group); SL, low-dose
Sophocarpine; SH, high-dose Sophocarpine.
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liver damage when they are excessively activated due to
stimulation by viral infection or chemical agents. In this
circumstance, their toxicity also correspondingly increases,
which results in ILI (Dong et al., 2004). The activity of NK
cells is regulated by a balance of positively and negatively
transduced signals that are initialized from cell surface receptors
(Raulet, 2004; Lanier, 2005). NKG2D, a receptor on the
NK cell membrane, has been the most extensively studied
for its essential role in NK cell activation. NKG2D is a
lectin-like type 2 transmembrane protein and irritant immune
receptor that typically couples with signaling adaptors that
contain an immune-receptor tyrosine-based activation motif
via interactions specified by their transmembrane regions.
Furthermore, NKG2D can associate with multiple adaptors,
include DAP12. Reportedly, the elimination of the DAP12
signaling complex can block the activating responses initialized
by NKG2D (Lanier, 2005). In this study, NKG2D and its
associated adaptor DAP12 are targeted.
Sophocarpine (Figure 1A) is a quinolizidine alkaloid extracted
from Radix Sophorae Subprostratae, a traditional Chinese herb
that has been used in the clinic for nearly 2000 years in China.
Similar in structure to matrine and oxymatrine, Sophocarpine has
two quinolizidine cycles in its basic nucleus. It has been reported
that Sophocarpine exerts an activity in immune modulation
(Zhang et al., 2007). It has also been found that Sophocarpine
is an effective agent in the treatment of viral myocarditis for
both its antiviral and antiarrhythmic properties (Zhang et al.,
2006). Furthermore, Sophocarpine has a therapeutic effect on
liver protection in that it can alleviate liver fibrosis by suppressing
both the activation of hepatic stellate cells and the proliferation
of the activated hepatic stellate cells (Yang et al., 2011). In spite
of those experimental studies and case reports, little work has
mentioned the effect of Sophocarpine on NK cell activity. Further,
whether Sophocarpine can alleviate ILI induced by the excessive
NK cell activation is also unclear.
The aim of this study is to fully explore the effects of
Sophocarpine on the prevention of Poly I: C/D-GalN-induced
NK cell over-activation in the liver and consequent ILI. It
also clarifies whether Sophocarpine may suppress the excessive
activation of NK cell by downregulating NKG2D and its adaptor
DAP12. According to our research, the results indicate a
prospective use of Sophocarpine in the therapy of ILI, and our
study provides a meaningful reference for ILI treatment in clinic.
RESULTS
Effects of Sophocarpine on Serum in the
Liver of Poly I: C and D-GalN-Induced
Mice
First, we investigated whether Sophocarpine attenuates Poly I:
C/D-GalN-induced ILI. The serum levels of ALT and AST,
two conventional indices indicating liver injury, were measured.
Compared with the control group, the ALT and AST in the
Poly I: C/D-GalN group were significantly increased by Poly
I: C/D-GalN (Figures 1B,C). The administration of high-dose
(SH, 120 mg/kg) and low-dose (SL, 60 mg/kg) Sophocarpine
significantly reduced the serum levels of ALT and AST,
respectively, compared with the PD group. Meanwhile, Poly I:
C/D-GalN treatment decreased the CHE, ALB and TP levels in
the serum, although this effect was attenuated by Sophocarpine
(Figures 1D–F).
Attenuation of Sophocarpine on
Immunological Liver Injury in Mice
Evidence of the protective effect of Sophocarpine on Poly I:
C/D-GalN-induced ILI was provided directly by histological
examination. The histology of liver tissues revealed hemorrhagic
lesions in the liver after it was exposed to Poly I: C/D-GalN,
which were not observed in the control group. Specifically, the
lesions exhibited centrilobular necrosis, immune cell infiltration
into the portal tract and sinusoid hepatocyte ballooning, necrosis,
and disintegration. Diffuse necrotic lesions with collections of
inflammatory cells, especially in the perivenous region, which
extends to the central zone, were observed after Poly I: C
and D-GalN injection. More importantly, SH administration
alleviated the severity of liver damage caused by Poly I:C/D-
GalN, resulting in a situation similar to the control group.
SL treatment moderately reduced both the inflammatory cell
infiltration and histological damage (Figure 2A). Furthermore,
pre-treatment with Sophocarpine alleviated signs of apoptosis
(Figure 2B).
Effect of Sophocarpine on
Pro-inflammatory Cytokine Secretion
Playing a critical role in the innate immune system, NK cells are
closely correlated with pro-inflammatory cytokine production.
TNF-α, IL-12 and INF-γ are essential pro-inflammatory
cytokines responsible for NK cell activity. Specifically, TNF-α can
stimulate NK cells to secrete IL-12 and INF-γ. Furthermore, IL-
12 can, in turn, activate NK cells, as suggested by an in vivo
study (Hou et al., 2009). To examine the effect of Sophocarpine
on the inflammatory response, the mRNA levels of TNF-α,
IL-12 and INF-γ in the liver tissue were detected. Compared
with the control group, the expression level of TNF-α in
the PD group increased by approximately 3.8-fold. Moreover,
the mRNA levels of INF-γ and IL-12 increased by nearly
22.1- and 66.1-fold, respectively. Sophocarpine significantly
downregulated the expression of TNF-α by 71.2% in the SH
group and by 41.9% in the SL group (Figure 3C). Furthermore,
Sophocarpine decreased the mRNA levels of INF-γ and IL-12
by 91.6 and 96.7% in the SH group and by 68.1 and 94.7%
in the SL group, respectively, compared with the PD group
(Figures 3A,B).
Sophocarpine Reduced NK Cell
Accumulation in the Liver
Poly I:C injection preferentially induced NK cell recruitment to
the liver (Dong et al., 2004). The effect of Sophocarpine on NK
cell accumulation was analyzed using flow cytometry. As shown
in Figures 4A,B, the proportion of NK cells in the liver increased
by nearly twofold after Poly I: C/D-GalN injection, which
Frontiers in Pharmacology | www.frontiersin.org 2 August 2016 | Volume 7 | Article 256
fphar-07-00256 August 10, 2016 Time: 12:21 # 3
Huang et al. Inhibition of Sophocarpineon Immunological Liver Injury
FIGURE 1 | Effects of Sophocarpine on serum in the liver of Poly I: C and D-GalN-induced mice. Mice were treated with 7.5 µg/20 g Poly I:C and
25 mg/20 g D-GalN, and they were pre-treated with different doses of Sophocarpine. (A) The structure of Sophocarpine. The figure shows the five liver function
markers in the serum: (B) ALT, (C) AST, (D) ALB, (E) CHE, and (F) TP. N = 20. Data are expressed as the mean ± SD. ##P < 0.01 compared with control group;
∗∗P < 0.01, ∗P < 0.05 compared with PD group. Poly I:C and D-GalN group (PD group), high-dose Sophocarpine group (SH group) and low-dose Sophocarpine
group (SL group).
was consistent with previous studies (Dong et al., 2004). After
Sophocarpine treatment, the proportion of NK cells decreased
by 50.1% in the SH group and by 43.8% in the SL group, thus
exhibiting a dose-dependent relationship. These consequences
suggested that Sophocarpine suppressed the accumulation of NK
cells in the liver.
Regulation of the NKG2D-DAP12
Signaling Pathway by Sophocarpine
Natural killer cells express a repertoire of activating receptors,
and NKG2D is reported to be a stimulatory immunoreceptor
that exists on the NK cell membrane. Previous reports have
demonstrated that human NK cells need to be ‘primed’ by
stimulation initialized from NK cell surface receptors, which
may trigger cytotoxicity in some abnormal conditions (Bryceson
et al., 2006). Therefore, we measured the expression of NKG2D
in mouse liver after Poly I: C/D-GalN induction due to its
essential role in NK cell activation. As shown in Figures 5A–C,
NKG2D expression was significantly higher in the PD group
than that in the control group. Sophocarpine clearly decreased
the expression level of NKG2D, and this effect was more
pronounced in the SH group. NKG2D activation can induce
changes both in its adaptor, DAP12, and in the down-stream
signaling pathways, which may initialize NK cell-driven ILI. The
association of NKG2D with DAP12 has significant consequences
for signal transduction in that DAP12 possesses a canonical
immunotyrosine-based activation motif (ITAM), which recruits
Syk and ZAP70 tyrosine kinases (7) (Lanier et al., 1998). To clarify
the mechanism underlying the inhibition of NK cell activation by
Sophocarpine, we investigated the expression levels of DAP12,
Syk, and ZAP70 (Figures 5D–G). Quantitative real-time PCR
revealed that Poly I: C/D-GalN-induced ILI was associated
with significantly upregulated DAP12, Syk, and ZAP70 mRNA
levels, and these change could be reversed by Sophocarpine
pre-treatment. Western blotting showed the expression of
DAP12, Syk, and ZAP70 in liver tissue samples from pre-
treated and untreated mice, and these assays demonstrated that
Sophocarpine was capable of downregulating the expression of
DAP12, Syk, and ZAP70. In addition, high-dose Sophocarpine
was more effective than low-dose Sophocarpine (Figures 5D–
G). Therefore, Sophocarpine might down-regulate the NKG2D-
DAP12 signaling pathways to attenuate Poly I: C/D-GalN-
induced ILI.
DISCUSSION
Due to an increasing interest in alternative medicine, many
studies have attempted to elucidate the mechanism underlying
the activity of the active compounds extracted from traditional
Chinese herbs. In previous studies, Sophocarpine, a quinolizidine
alkaloid extracted from Radix Sophorae Subprostratae, has
been reported to exert activity on immune regulation (Zhang
et al., 2007), and it is hepato-protective against hepatic
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FIGURE 2 | The intervention effects of Sophocarpine on immunological liver injury. Mice were treated with different doses of Sophocarpine. Positive
expression in H&E and TUNEL Staining is displayed by the black arrows. (A) Representative photographs of 10 animals show the effect of Sophocarpine, which was
confirmed by H&E. Blue is cytoplasm and red is nucleus; N = 10. (B) The effect of Sophocarpine pre-treatment on apoptotic cells; blue is nucleus and DAB showing
positive expression is tan; N = 5. Poly I:C and D-GalN group (PD group), high-dose Sophocarpine group (SH group) and low-dose Sophocarpine group (SL group).
FIGURE 3 | Effect of Sophocarpine on pro-inflammatory cytokine secretion. Mice were treated with different doses of Sophocarpine and detected by
Q-PCR. (A) The mRNA levels of IL-12 and (B) INF-γ; (C) The concentration of TNF-α in the mice liver tissue; N = 10. #P < 0.05, ##P < 0.01 compared with control
group; ∗P < 0.05, ∗∗P < 0.01 compared with PD group. Poly I:C and D-GalN group (PD group), high-dose Sophocarpine group (SH group) and low-dose
Sophocarpine group (SL group).
fibrosis in rats (Qian, 2008). In our study, pre-treatment with
Sophocarpine significantly and dose-dependently downregulated
the levels of ALT and AST and upregulated the levels of
TP, CHE and ALB. Furthermore, Sophocarpine pre-treatment
significantly attenuated liver tissue damage, as evidenced by
histology.
Natural killer cells, the major innate immune cells in the
liver, play an important role in the innate immune response
against liver injury (Kärre, 2002). Unlike T and B cells, NK
cells lack variable receptors that recognize foreign antigens,
but they express inhibitory and activating receptors to balance
their activation (Samarakoon et al., 2009). The ability of various
natural products or artificially synthesized compounds to recruit
and activate NK cells has been studied (Wiltrout et al., 1989).
Polyinosinic-polycytidylic acid (Poly I: C) is a self-peptide that
is used to induce chronic and severe pancreatitis in MRL/+mice
(Jiang et al., 2005). Additionally, Poly I:C/D-GalN synergistically
induced the production of INF-γ and TNF-α, although D-GalN
alone did not elevate the levels of either cytokine, as previously
reported (André et al., 2004; Rosen et al., 2004; Huang et al.,
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FIGURE 4 | The effect of Sophocarpine on the accumulation of NK cells in the liver. Mice were treated with different doses of Sophocarpine for 12 days and
injected with Poly I: C/D-GalN. Lymphocytes were isolated from the liver, and the surface expressions of NK cells, which were marked by CD3e and CD49b, were
detected by flow cytometry. (A,B) Are the total number of NK cells in the liver calculated by multiplication with the respective percentage of lymphocytes; N = 10.
##P < 0.01 compared with control group; ∗∗P < 0.01 compared with PD group. Poly I: C and D-GalN group (PD group), high-dose Sophocarpine group (SH group)
and low-dose Sophocarpine group (SL group).
FIGURE 5 | Regulation of the NKG2D-DAP12 signaling pathway by Sophocarpine. C57BL/6 mice were injected with Poly I:C and simultaneously
intraperitoneally injected with D-GalN. Hepatic lymphocytes were isolated, and the expression of NKG2D on the NK cell surface was detected by flow cytometry
(A), whereas the expression of NKG2D (B), DAP12 (D), ZAP70 (E), and Syk (F) were analyzed by Q-PCR; N = 10. Western blotting was used to analyze the protein
level of NKG2D (C), DAP12, ZAP70, and Syk (G); N = 3. ##P < 0.01 compared with control group; ∗∗P < 0.05 compared with PD group. Poly I:C and D-GalN
group (PD group), high-dose Sophocarpine group (SH group) and low-dose Sophocarpine group (SL group).
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2013). The synergistic effect of Poly I: C/D-Ga1N on IL-12 is
similar to that on INF-γ and TNF-α. In our studies, pre-treatment
with Sophocarpine successfully inhibited the abnormal TNF-α,
INF-γ, and IL-12 production induced by Poly I: C/D-GalN,
which alleviated inflammation and led to liver damage. We also
verified the therapeutic potential of Sophocarpine in vivo by
demonstrating that this inhibitory effect is related to a decrease
of accumulation of NK cells in the liver.
The balance between activating and inhibiting signals of NK
cells is mediated by various receptors by which NK cell function
is regulated (Martinovic´ et al., 2015). NKG2D is the activating
receptor on the surface of NK cells, and NK cell-mediated ILI by
NKG2D-DAP12 (Lanier, 2005) the signaling pathway is a critical
step. Interestingly and importantly, our study demonstrated that
Sophocarpine could block the upregulation of both NKG2D
and its adaptor, DAP12. Furthermore, Syk and ZAP70 tyrosine
kinase, two key members in downstream signaling, were also
downregulated following the administration of Sophocarpine,
potentially indicating the mechanism underlying the therapeutic
activity on ILI of Sophocarpine.
The expression of the NKG2D protein on the surface of NK
cells requires interactions with its adapter protein to stabilize
the receptor complex (Lanier, 2015). Mice express two isoforms
of NKG2D protein as a result of alternative splicing. NK
cells in resting mice express a longer (NKG2D-L) protein that
is exclusively and non-covalently associating with the DAP10
adapter protein, whereas the activation of mice NK cells induces
the alternative splicing of Klrk 1, resulting in a shorter (NKG2D-
S) protein isoform that correlates with either DAP10 or DAP12
adapter protein (Diefenbach et al., 2002; Gilfillan et al., 2002).
A previous study showed that association of NKG2D with
DAP12 has significant consequences for signal transduction in
that DAP12 possesses a canonicalITAM, which recruits and
activates Syk and ZAP70 tyrosine kinases (Lanier et al., 1998),
thus causing the activation of NK cells (Lanier et al., 1998;
Cantoni et al., 1999; Wu et al., 2000; Jiang et al., 2002). Syk, a
protein tyrosine kinase, plays a crucial role in intracellular signal
transduction in hematopoietic cells and interacts with immune-
receptor tyrosine-based activation motifs (ITAMs) located in
the cytoplasmic domains of immune receptors. It couples the
downstream signaling events of activated immunoreceptors
that mediate diverse cellular responses, including proliferation,
differentiation, and phagocytosis. The Syk family protein tyrosine
kinase ZAP70 is expressed in T and NK cells and plays
an essential role in regulating NK cell activation. DAP12
receptor complex is largely intact, whereas the transcription of
cytokine genes is completely abrogated (Huntington et al., 2005;
Hesslein et al., 2006; Mason et al., 2006). Thus, the two major
functions of NK cells—cytokine secretion and cytotoxicity—
are differentially regulated downstream of ITAM-containing
NK receptors. As demonstrated in this study, the mRNA
expression of Syk and ZAP70 was reduced by Sophocarpine.
Moreover, the Western blot and immunohistochemistry results
demonstrated that the protein levels of Syk and ZAP70 also
declined.
This study demonstrated that Sophocarpine affects Poly I:
C/D-GalN-induced ILI in mice. Sophocarpine significantly
TABLE 1 | Forward and reverse primers used in reverse transcription
polymerase chain reaction.
Mouse
gene
Sense primer (5′–3′) Antisense primer (5′–3′)
IL-12 5′-TCA CAT CTG CTG CTC
CAC AAG-3′
5′-AGC CAT GAG CAC GTG
AAC C-3′
INF-γ 5′-TAC TGC CAC GGC AC A
GTC AT-3′
5′-TGC CAG TTC CTC CAG
ATA TCC-3′
NKG2D 5′-GGC TTG CCA TTT TCA
AAG AG-3′
5′-TGA GCC ATA GAC AGC
ACA GG-3′
GAPDH 5′-GTC CTC AGC GTA GCC
CAA GAT G-3′
5′-CAA TGT GTC CGT CGT
GGA TCT-3′
SYK 5′-CCA GAC AGA GGC CTT
CAG AGA-3′
5′-AGC AGG CTC CTG TCC
AGG TA-3′
ZAP70 5′-TGC GCA AGA AGC AGA
TTG AC-3′
5′-ATG AGC CGC ACG ATG
TAG G-3′
TNF-α 5′-GCC TCT TCT CAT TCC
TGC TTG T-3′
5′-TTG AGA TCC ATG CCG
TTG-3′
DAP12 5′-AGG CCC AGA GTG ACA
CTT TCC-3′
5′-GTA CAC AGC CAG GGC
AAT CAG-3′
reduced the percentage of dead cells and ameliorated
histopathology and morphological injury. Furthermore, it
decreased the accumulation of NK cells by downregulating the
NKG2D-DAP12 signaling pathway. Therefore, the present study
suggests that Sophocarpine may be used to protect the liver
from ILI. Although this application requires future clinical trials,
our study still provides a promising therapeutic approach and
meaningful reference for clinical practice.
MATERIALS AND METHODS
Animal
All animal procedures were approved by the Animal Experiment
Committee of the 302 Military Hospital of the People’s Liberation
Army. Male C57BL/6 mice weighing 20 ± 2 g were obtained
from the laboratory animal center of the Sibei Fu (Beijing)
Laboratory Animal Science and Technology Corporation. Food
and water were available ad libitum. All studies were performed
in accordance with the guidelines of the Council on Animal
Care of the Academia Sinica. The animals were randomly
divided into four groups with twenty mice in each group.
Sophocarpine (Us150218) was dissolved in normal saline and
intragastrically administered to mice (60 mg/kg for the low dose
and 120 mg/kg for the high dose) for 12 days. Finally, all animals
in each group except the control group were intravenously
injected with Polyinosinic-polycytidylic acid sodium (Poly I: C,
Sigma) dissolved in pyrogen-fee saline at a concentration of
75 µg/kg (Huang et al., 2013). The mice were simultaneously
intraperitoneally injected with D-galactosamine (D-GalN, Sigma)
at a dose of 500 mg/kg (Huang et al., 2013). The mice
were sacrificed 12 h after injection. The blood and liver were
collected. The blood was centrifuged at 3000 g for 10 min to
separate the serum without hemolysis. All of the serum and
the rest of the liver tissue after hematoxylin-eosin staining were
stored at−80◦C.
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FIGURE 6 | Experimental flow chart and the probable protection mechanism of Sophocarpine in liver injury.
Blood Chemistry Analysis
The serum levels of AST, ALT, CHE, ALB, and TP were measured
using an automatic biochemical analyzer (BS-300) and assay kits
bought from Wan Tai Drd. All assays were performed according
to the manufacturer’s protocol.
Histopathological Evaluations and
Immunohistochemical Observation
The liver tissues obtained from the experimental mice were fixed
in 10% neutral buffered formalin, embedded in paraffin. The
embedded tissues were cut into 5-µm-thick sections and disposed
using hematoxylin-eosin (H&E) and TUNEL Staining. As for
H&E staining, cytoplasm was stained in blue and the nucleus
stained in red, while for TUNEL Staining the nucleus was stained
in blue and DAB showing a positive expression was tan.
Flow Cytometric Analysis of the Number
of NK Cells and NK Cell-Membrane
Receptors
The cells were stained with the indicated fluorescence-
labeled mAba for surface antigens according to a standard
protocol. For intracellular cytokine staining, the cells were fixed,
permeabilized, and stained with APC-Cy7 Hamster Anti-Mice
CD3e (BD Pharmingen 557596), FITC Rat Anti-Mouse CD49b
(BD Pharmingen 553857), PE Rat anti-Mouse NKG2D (BD
Pharmingen 558403). The stained cells were analyzed using
a flow cytometer (BD FACSCantoTM II), and the data were
analyzed using FlowJo 7.6.1.
RNA Extraction and
Reverse-Transcriptase Quantitative PCR
The total RNA was extracted using TRIzol (Life Sciences) and
reverse-transcribed in 50 µl of solution using the Revert kit
(Thermo-Fisher). The mRNA level expression was quantitated
using real-time PCR (Applied Biosystems 7500 Real Time PCR
System) and a SYBR Green PCR Master Mix kit (life). The
primers for NKG2D, DAP12, Syk, ZAP70, and GAPDH are given
in Table 1. The gene expression values were calculated based on
the 11Ct method as described previously using the mean of the
respective cytokines in mock-treated mice as a calibrator. The
relative quantities (RQs) were determined using the following
equation: RQ= 2(−11Ct) (Table 1).
Western Blot for the Levels of NKG2D,
DAP12, Syk, and ZAP70 in Liver Tissue
Mice liver tissue (0.15 g) was homogenized and subsequently
lysed on ice with RIPA buffer (G2002) containing a protease
inhibitor mixture. The sample was subjected to centrifugation
at 12000 rpm and 4◦C for 10 min to separate any debris. After
centrifugation, 800 µl of supernatant was stored at −80◦C.
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These samples were used to detect the presence of NKG2D,
DAP12, ZAP70, and Syk. Antibodies against DAP12 (sc7853),
NKG2D (sc-292424), Syk (D3Z1E), ZAP70 (A2195), and β-actin
(GB13001-1) were diluted in a solution of 5% milk, Tris-buffered
saline (TBS), and 0.05% Tween-20 to detect NKG2D, DAP12,
Syk, ZAP70, and β-actin, respectively. After incubation with
the appropriate peroxidase-conjugated secondary antibody, the
membrane was washed in TBST for 5 min and detected using
a Western blotting detection system (Quantity One, Bio-Rad
Laboratories, USA).
Study Design
The mice were randomly divided into four groups (control, PD,
SH, and SL) in the whole study. Sophocarpine was administered
intragastrically, and the control group and PD group were treated
with saline for 12 days, once a day. After 12 days, all animals
except those in the control group were intravenously injected
with Polyinosinic-polycytidylic acid sodium (Poly I: C, Sigma)
dissolved in pyrogen-fee saline at a concentration of 75 µg/kg
(Huang et al., 2013) and simultaneously intraperitoneally injected
with D-galactosamine (D-GalN, Sigma) at a dose of 500 mg/kg
(Huang et al., 2013). D-GalN, when used as a sensitization agent,
can increase the sensitivity of NK cells, and Poly I: C is able to
activate NK cells. The mice were sacrificed 12 h after injection
with the collection of blood and liver tissue for the hepatic index
detection and NK cell related proteins (Figure 6).
Statistics
The data are expressed as the mean ± standard deviation (SD)
and were analyzed using the SPSS software (version 20.0; SPSS,
Inc., Chicago, IL, USA). The differences between the group means
were assessed based on the mean ± standard error of the mean
(SEM). The differences were considered to be significant when
P < 0.05 and highly significant when P < 0.01.
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